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The association between ambient ﬁne particu-
late matter (PM) air pollution [particles with
aerodynamic diameter ≤ 2.5 µm (PM2.5)] and
increased cardiovascular morbidity and mor-
tality in epidemiologic studies (Dominici et al.
2006; Miller et al. 2007; Pope et al. 2002) has
led to investigation of underlying mecha-
nisms, which remain cryptic (Bhatnagar
2006). Several studies link ambient (especially
combustion-derived) PM with increased vas-
cular tone (Brook et al. 2002; Campen et al.
2005; Proctor et al. 2006), and animal studies
showed possible involvement of sympathetic
nervous system activation (Proctor et al. 2006)
and vasoconstriction pathways (Bouthillier
et al. 1998; Li et al. 2005). Evidence suggests
that the effect of PM on vascular reactivity
may be greater in individuals at risk for coro-
nary artery disease (O’Neill et al. 2005).
Human studies to date have provided limited
insight into the mechanism of the vascular
effects of PM, although recent evidence has
documented enhanced exercise-induced
ischemia with controlled exposure to diesel
exhaust (DE) (Mills et al. 2007).
DE is a complex mixture of particulate and
gaseous pollutants that comprise a substantial
and biologically active fraction of urban ambi-
ent air pollution (Health Effects Institute
1995) and is a very appropriate experimental
model exposure, especially with the current
interest in traffic-related air pollution.
Evidence suggests that inhalation of DE is
associated with perturbation in endothelial
function (Campen et al. 2005; Mills et al.
2005; Tornqvist et al. 2007). We exposed
young adults, healthy or with metabolic syn-
drome, to DE under controlled settings.
Young adults with metabolic syndrome have
increased subclinical atherosclerosis (Tzou
et al. 2005) and are at increased risk for cardio-
vascular morbidity and mortality (Isomaa et al.
2001). We focused on individuals with meta-
bolic syndrome because they might be more
susceptible to DE effects. We hypothesized
that DE inhalation would result in vaso-
constriction and decreased endothelium-
dependent ﬂow-mediated dilation (FMD) of
the brachial artery within 30 min of exposure.
We also hypothesized that vascular effects of
DE might be related to activation of the sym-
pathetic nervous system or increased release of
the endothelium-dependent vasoconstrictor
endothelin-1 (ET-1). 
Materials and Methods
We conducted a crossover, double-blind
experiment, randomized to order, of DE
inhalation and a sham [ﬁltered air (FA) only]
exposure, with each participant exposed on
three different days to each of three condi-
tions: FA, and DE calibrated to 100 µg/m3
(DE100) and 200 µg/m3 (DE200) PM2.5. 
Study participants. Participants were
recruited if they were 18–49 years of age, non-
smokers for at least 6 months, with no history
of ongoing medical care for heart disease,
hypertension, asthma, diabetes, hyper-
cholesterolemia, or other chronic condition;
all had normal spirometry. We separately
recruited and randomized participants who
were healthy or had metabolic syndrome.
Healthy participants had body mass index
(BMI) < 30 kg/m2, fasting blood sugar < 126
mg/dL, no signs of arrhythmia or ischemia on
electrocardiogram (ECG), and blood pressure
< 130/85 mmHg. Metabolic syndrome partic-
ipants fulﬁlled any three of the following ﬁve
criteria: waist circumference ≥ 102 cm in
males and ≥ 88 cm in females; triglycerides
≥ 150 mg/dL; HDL cholesterol < 40 mg/dL
in males and < 50 mg/dL in females; systolic
blood pressure ≥ 130 mmHg or diastolic
blood pressure ≥ 85 mmHg; fasting glucose
≥ 100 mg/dL (Grundy et al. 2005).
All participants gave written informed
consent. The consent form and study proto-
col were approved by the University of
Washington Human Subjects Division.
Exposure session protocol. Exposures began
at approximately 0900 hours and were 2 hr in
duration; participants were at rest throughout.
Exposures were separated by at least 2 weeks.
Women were exposed only during the first
2 weeks of the menstrual cycle, after the end
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BACKGROUND: Trafﬁc-related air pollution is consistently associated with cardiovascular morbidity
and mortality. Recent human and animal studies suggest that exposure to air pollutants affects vas-
cular function. Diesel exhaust (DE) is a major source of trafﬁc-related air pollution.
OBJECTIVES: Our goal was to study the effects of short-term exposure to DE on vascular reactivity
and on mediators of vascular tone. 
METHODS: In a double-blind, crossover, controlled exposure study, 27 adult volunteers (10 healthy
and 17 with metabolic syndrome) were exposed in randomized order to ﬁltered air (FA) and each of
two levels of diluted DE (100 or 200 µg/m3 of ﬁne particulate matter) in 2-hr sessions. Before and
after each exposure, we assessed the brachial artery diameter (BAd) by B-mode ultrasound and col-
lected blood samples for endothelin-1 (ET-1) and catecholamines. Postexposure we also assessed
endothelium-dependent ﬂow-mediated dilation (FMD). 
RESULTS: Compared with FA, DE at 200 µg/m3 elicited a decrease in BAd (0.11 mm; 95% conﬁ-
dence interval, 0.02–0.18), and the effect appeared linearly dose related with a smaller effect at 100
µg/m3. Plasma levels of ET-1 increased after 200 µg/m3 DE but not after FA (p = 0.01). There was
no consistent impact of DE on plasma catecholamines or FMD. 
CONCLUSIONS: These results demonstrate that short-term exposure to DE is associated with acute
endothelial response and vasoconstriction of a conductance artery. Elucidation of the signaling
pathways controlling vascular tone that underlie this observation requires further study.
KEY WORDS: air pollution, brachial artery, catecholamines, endothelin-1, vasoconstriction. Environ
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[Online 18 March 2008]of menstrual flow, to comprise the follicular
phase. Participants fasted (other than water) for
at least 10 hr before each visit and throughout
the study session. On arrival, an intravenous
catheter was placed in the left arm of the par-
ticipant for preexposure and subsequent blood
draws. About 30 min later, we measured pre-
exposure brachial artery diameter (BAd) on the
participant’s right arm. Thirty minutes after
the exposure ended, BAd was measured again,
along with response to inflation of a cuff on
the proximal arm (FMD). A postexposure
blood draw was performed at 3 hr from the
onset of exposure (~ 30 min after ultrasound
measurement). Arterial blood pressure was
measured one time before each BAd measure-
ment on the participant’s left arm.
Exposure system. Characteristics of the
exposure system have been described (Gould
et al. 2008). Briefly, DE was derived from a
2002 model turbocharged direct-injection
5.9-L Cummins B-series engine (6BT5.9G6;
Cummins, Inc., Columbus, IN) in a genera-
tor set. Load was maintained at 75% of rated
capacity, using a load-adjusting load bank
(Simplex, Springfield, IL) throughout the
exposures. We used no. 2 undyed, on-high-
way fuel and Valvoline 15W-40 crankcase oil.
Fuel deliveries were regularly tested for aro-
matics and sulfur content. Emissions were
diluted in two phases, resulting in final
breathing zone concentrations that could be
calibrated between 15 and 400 µg/m3 PM2.5.
Crankcase emissions were not entrained into
the exposure system. All dilution air for the
system was passed through HEPA and carbon
filters, permitting an FA control exposure
option with very low particulate and gaseous
organic pollutant levels. The air entering the
exposure room was conditioned to 18°C and
60% relative humidity. During exposures,
PM2.5 concentrations were continuously
measured and dynamically adjusted to main-
tain steady-state conditions [tapered element
oscillating microbalance (TEOM); 1400a
PM2.5; Rupprecht & Patashnick Co.,
Albany, NY]. Multistage samples collected on
a micro-orifice uniform deposition impactor
(MOUDI; MSP, Shoreview, MN) indicated a
mass median diameter of 0.104 µm (geo-
metric SD = 1.15) determined from 100 and
200 µg/m3 sample sessions. The facility main-
tains low concentrations of the gaseous copol-
lutants carbon monoxide and nitrogen
dioxide (Table 1). One-minute averages
(± SE) of particle numbers (particles per cubic
centimeter) during exposure (condensation
particle counter, model 3022A; TSI, Inc.,
Shoreview, MN) were 2889.5 ± 780.3 for FA;
30590.2 ± 2427.6 for DE100; and 52840.9 ±
6860.9 for DE200.
Brachial artery studies. All measurements
of BAd and FMD were performed using previ-
ously described methods (Corretti et al. 2002;
Peretz et al. 2007). Studies were performed in
a quiet and dark room and at controlled ambi-
ent temperatures between 20 and 26°C. Blood
pressure was measured on the left arm before
each study. The electrocardiogram was contin-
uously monitored. In supine position, and after
10 min of rest, the right arm of the participant
was comfortably immobilized in the extended
position, allowing for ultrasound scanning of
the brachial artery above the antecubital fossa.
The location of the ultrasound probe during
the participant’s first test was recorded and
used for later tests in that subject. 
One experienced sonographer, blinded to
exposure concentrations, scanned the brachial
artery in longitudinal orientation using an HDI
5000 Ultrasound Instrument (Philips Medical
Systems, Bothell, WA) with a 5–12 MHz lin-
ear array transducer. In each examination,
preexposure recording of vessel images fol-
lowed baseline Doppler assessment of blood
flow velocity. After exposure, vessel images
were again recorded, followed by inﬂation of
a cuff on the upper arm to 50 mmHg above
systolic pressure for 5 min. The blood pres-
sure cuff was placed proximal to the location
of the ultrasound probe. Blood ﬂow velocity
was then obtained after cuff release, and the
brachial artery was imaged and recorded for
5 min. Images were digitized from the video
output of the ultrasound machine using a
frame grabber under control of custom soft-
ware on a personal computer. Image acquisi-
tion was gated with ECG signal to capture
end diastole in each cardiac cycle. 
BAd was assessed by a single trained opera-
tor using a validated and automated, beat-by-
beat image-processing software package
(Vascular Tools 4.6; Medical Imaging
Applications, Coralville, IA) previously intro-
duced (Sonka and Lauer 2002) and indepen-
dently validated (Mancini et al. 2002; Preik
et al. 2000). Brieﬂy, the operator deﬁned a vas-
cular region of interest, which was then applied
automatically to identify the media-to-media
diameters in each frame over time. We
excluded from analysis those frames with
detected vessel border < 70% of the width of
the region of interest (conﬁdence index < 70%)
and, for postcuff deﬂation sessions only, frames
with diameters that differed by > 1 SD from a
polynomial ﬁt. Custom software developed in
the MATLAB programming environment
(MathWorks, Natick, MA) was used to extract
measurements from the time series of diameter
measurements. We previously reported a small
day-to-day variability of baseline BAd for the
described methods (coefﬁcient of variation =
5.1 ± 1.7%) (Peretz et al. 2007).
We determined changes in BAd after each
exposure session by calculating the difference
between postexposure measurement and pre-
exposure measurement. Decreases in BAd after
exposures were considered vasoconstriction,
whereas increases were termed vasodilation.
FMD was calculated as percent difference of
the maximal diameter after cuff deﬂation from
the postexposure BAd.
Plasma ET-1. Whole blood samples were
collected in potassium citrate; plasma was
aliquoted and frozen at –70°C within 30 min
of blood draw, and batch run. After extraction
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Table 1. Average PM2.5 mass concentrationsa and gas concentrationsb measured during 2-hr exposure
sessions of 27 participants.
Pollutant FA 100  µg/m3 DE 200 µg/m3 DE
PM2.5 (µg/m3) 4.60 101.53 205.33
NO2 (ppb) 15.89 16.53 24.67
NO (ppb) 40.49 958.14 1537.93
CO (ppm) 0.27 0.51 0.89
aFrom TEOM; discrete 10-min averaging intervals. b1-min averaging intervals.
Table 2. Characteristics of study participants (n = 27) by health status.
Characteristic Healthy Metabolic syndrome
Participants (no.) 10 17
Age, years [mean (range)] 29.8 (20–42) 38.5 (20–48)
Sex [female:male (no.)] 2:8 6:11
Race (no.)
Caucasian 7 13
African American 2 2
Asian 1 1
Other 0 1
Body mass index (kg/m2) 24.5 ± 0.5* 42 ± 1.9*
Blood pressure (mmHg)a
Systolic 108 ± 3.8* 123 ± 2.2*
Diastolic 75 ± 2.9* 83 ± 1.6*
Total cholesterol (mg/dL) 151.1 ± 9.9* 194.8 ± 7.7*
Triglycerides (mg/dL) 70.8 ± 13.6* 177 ± 27.1*
Glucose (mg/dL) 88.9 ± 1.9* 99.7 ± 2.6*
Where not speciﬁed, values are mean ± SE. 
aMeasure at preexposure. *p < 0.01.from plasma, ET-1 levels were measured by
ELISA (R&D systems, Minneapolis, MN). We
assayed only samples collected at FA and DE200
exposure sessions. We report a mean concentra-
tion of ET-1 in picograms per milliliter. 
Plasma catecholamines and metabolites. To
assess activity of the sympathetic nervous system
at serial time points, we assayed plasma levels of
catecholamine precursor L-3-4-dihydroxypheny-
lalanine (L-DOPA); catecholamines norepi-
nephrine (NE), epinephrine, and dopamine;
deaminated metabolites of NE-dihydroxy-
phenylglycol (DHPG); and dopamine dihy-
droxyphenylacetic acid (DOPAC). Whole
blood samples were collected in lithium heparin
and chilled immediately after draw. Within
15 min of sample collection, plasma was sepa-
rated (1,000 × g, 2,400 rpm, CR412 centrifuge,
4°C, 10 min) and stored in sterile polypropylene
cryotubes at –80°C. Plasma was extracted with
adaptation of alumina method of Anton and
Sayre (1962) (ESA, Inc., Chelmsford, MA), sep-
arated by high-performance liquid chromatogra-
phy using a reverse-phase C-18 column, and
measured by electrochemical detection
(Coulechem II; ESA, Inc.). The coefﬁcients of
variation (CV) for the assays used are 7.05%
[intraassay CV, based on intraassay variation in
internal reference standard 3,4-dihydroxy-
benzylamine (DHBA)] and 10.81% (interassay
CV, based on pooled plasma samples repeated
in each assay). We assayed only samples col-
lected at FA and DE200 exposure sessions.
Statistical analysis. All statistical testing
was based on two-tailed p-values with α =
0.05. Descriptive data are presented as mean ±
SE unless speciﬁed otherwise. Statistical analy-
ses were performed using STATA 9.1
(StataCorp., College Station, TX).
Plasma catecholamines values were natural
log-transformed for analysis. Changes attribut-
able to exposure are the difference between
postexposure and preexposure for BAd, ET-1,
and catecholamines. Comparisons of study
vascular and plasma end points between DE
and FA exposures were made by paired t-test.
We used analysis of variance (ANOVA) to
compare averages of preexposure BAd between
exposures. We tested for effect modification
by subject-related characteristics and for
period and carryover effects, using ANOVA.
Results
Twenty-seven participants completed all three
exposure sessions: 10 healthy and 17 with
metabolic syndrome, with characteristics
shown in Table 2. 
Vessel caliber studies. Data were not avail-
able from four healthy participants for pre-
exposure BAd; one participant had missing
preexposure BAd data from the FA exposure
session; and one participant had missing pre-
exposure and postexposure BAd data from the
DE100 exposure session. 
Overall, 22 participants had paired pre-
exposure and postexposure BAd data for the
FA and DE200 exposure comparisons, and 21
participants had data for the FA and DE100
exposure comparisons. The average preexpo-
sure BAd was not statistically different
between FA (3.94 mm), DE100 (4.06 mm),
and DE200 (4.09 mm) (p = 0.6). 
Average BAd measures before and after
exposures are presented in Table 3. Of the 22
participants with paired BAd measurements in
both DE200 and FA, 16 had smaller vessel cal-
iber after DE than FA: 4 demonstrated vaso-
constriction with DE and dilation with FA, 10
demonstrated greater degree of vasoconstric-
tion with DE than FA, and 2 demonstrated
blunted vasodilation with DE compared with
FA (Figure 1A). Overall, exposure to DE200
was associated with an average 0.11-mm
greater degree of constriction of the brachial
artery than exposure to FA (p = 0.01).
Exposure to DE100 was also associated with a
greater degree of arterial constriction than
exposure to FA (–0.05 mm), but the differ-
ence was not statistically signiﬁcant. Of note,
the point estimate of this effect is half that
observed with DE200, making a linear
dose–response effect the most likely explana-
tion (Figure 1B). Age, sex, BMI, fasting
plasma lipid levels, carryover, and period
effects did not modify the association between
DE and vasoconstriction. There was no effect
of DE on systolic or diastolic blood pressure
(data not shown).
FMD. All 27 participants had paired FMD
data for FA and DE200 exposure comparisons,
Vascular effects of diesel exhaust
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Table 3. BAd at baseline and after ﬂow-mediated dilation (mean ± SE).
Healthy Metabolic syndrome All
BAd (mm) n = 5 n = 16/17a n = 21/22a
FA
Preexposure 3.48 ± 0.26 4.08 ± 0.14 3.94 ± 0.14
Postexposure 3.46 ± 0.25 4.07 ± 0.15 3.93 ± 0.14
100 µg/m3 DE 
Preexposure 3.79 ± 0.31 4.15 ± 0.15 4.06 ± 0.13
Postexposure 3.64 ± 0.29 4.10 ± 0.16 3.99 ± 0.14
200 µg/m3 DE
Preexposure 3.88 ± 0.39 4.15 ± 0.14 4.09 ± 0.14
Postexposure 3.64 ± 0.29 4.07 ± 0.15 3.97 ± 0.13
FMD (%) n = 10 n = 16/17a n = 26/27a
FA 15.0 ± 1.7 13.3 ± 1.1 13.9 ± 0.9
100 µg/m3 DE 15.8 ± 1.3 16.2 ± 1.3 16.1 ± 1.1
200 µg/m3 DE 16.9 ± 2.0 15.5 ± 1.1 16.0 ± 1.0
aSixteen participants with metabolic syndrome had available paired data for DE at 100 µg/m3 and FA comparisons; 17 had
available paired data for DE at 200 µg/m3 and FA. The total number of subjects with paired data is smaller for DE at
100 µg/m3 and FA comparisons versus DE at 200 µg/m3 and FA comparisons. 
Figure 1. Changes in BAd after exposures. CI, confidence interval. (A) Individual changes in BAd after
exposures to 200 µg/m3 DE or FA. The difference in millimeters in resting BAd between postexposure and
preexposure (ΔBAd) in each of the two exposure conditions is shown. Individual subjects are designated
by M for metabolic syndrome or H for healthy. The lines demonstrate mean ΔBAd at each exposure level.
(B) Dose–response relationship of DE effect on BAd. Bars for each DE exposure concentration demon-
strate the mean and 95% CI of DE vasoconstrictive effect in reference to FA represented as no vaso-
constriction (X – = 0) for the two study subpopulations and the overall group. Wide CIs for the healthy group
reﬂect the small sample size and not higher variance. 
0.25
0.15
0.05
0.00
–0.05
–0.15
–0.25
–0.75
FA 200 μg/m3 DE
Δ
B
A
d
 
(
m
m
)
–0.2 0.0 0.2 0.4 0.6
200 μg/m3
DE
100 μg/m3
DE
Vasoconstrictive DE effect,
mm (ΔBAdFA-ΔBAdDE),
X, 95% CI
FA
Metabolic syndrome
Healthy
All participants
A B Metabolic syndrome
Healthy
All participantsand 26 participants had data for FA and DE100
exposure comparisons (Table 3). Exposure to
DE200 elicited a greater, but not statistically
signiﬁcant, FMD (16.0%) compared with FA
(13.9%) (p = 0.07). A similar effect was
observed comparing DE100 and FA. Health
status of participants did not affect the differ-
ences in FMD between DE and FA.
Plasma analytes. Averages of plasma hor-
mones for exposures to DE200 and FA are
shown in Table 4. Twenty-two participants
(6 healthy and 16 metabolic syndrome) had
paired preexposure and postexposure ET-1
samples from both DE200 and FA exposures.
Exposure to DE200 was associated with an
increase in plasma ET-1 levels at 3 hr [Δ =
0.43; 95% confidence interval (CI), 0.25 to
0.61], whereas the levels were nearly unchanged
after FA (Δ = 0.01; 95% CI, –0.28 to 0.31)
(Figure 2). The impact of DE200 on plasma
ET-1 compared with FA was statistically sig-
niﬁcant (p = 0.01). Healthy participants had,
on average, greater increments in plasma levels
of ET-1 after DE200 (Δ = 0.76; 95% CI, 0.38
to 1.1) compared with participants with meta-
bolic syndrome (Δ = 0.31; 95% CI, 0.12 to
0.51) (p = 0.02). 
We compared ET-1 response between
vasoconstrictors (participants who demon-
strated vasoconstriction with exposure to
DE200 or more vasoconstriction from DE200
than from FA) (n = 14) and nonvasoconstric-
tors (n = 8). The increment in plasma ET-1
3 hr after exposure to DE200 was greater in
vasoconstrictors than nonvasoconstrictors,
but not significant. Plasma levels of ET-1 at
3 hr were not different between DE200
(0.33 pg/mL) and FA (0.34 pg/mL) for
nonvasoconstrictors (p = 0.9), whereas vaso-
constrictors had higher levels 3 hr post-DE200
(0.38 pg/mL) compared with FA (0.26 pg/mL)
(p = 0.06).
Because of insufﬁcient sample availability,
only 13 participants (5 healthy and 8 metabolic
syndrome) had paired preexposure and post-
exposure sympathetic marker samples from
both DE200 and FA exposures. Two subjects
with extremely high values of DHPG (for one)
and DOPAC (for the other) were considered
outliers and were excluded from the statistical
analysis. Epinephrine and dopamine were not
compared between FA and DE because of a
very low signal-to-noise ratio of the assay. 
Except for NE, all sympathetic plasma
markers tended to be increased at 3 hr after
exposure to DE200 to a greater extent than the
changes after exposure to FA (Figure 2). Only
the difference in exposure-related changes of
L-DOPA (Δ = 0.11; 95% CI, 0.01 to 0.22)
was statistically signiﬁcant. 
Discussion
In this study we demonstrated that controlled
exposure to DE, a major source of urban air
pollution, acutely affects vascular tone in
humans. These results add to previous evi-
dence of vascular dysfunction after exposure
to DE (Mills et al. 2005) and vasoconstriction
associated with pollutant particles in humans
(Brook et al. 2002) and animal models
(Batalha et al. 2002; Huang et al. 2002;
Proctor et al. 2006). Our data suggest, for the
ﬁrst time in humans, that endothelins includ-
ing ET-1 may be involved in the vascular
effect of DE. This provides a potentially vital
insight into the pathways responsible for car-
diovascular health effects of combustion-
derived air pollution.
Although the absolute magnitude of DE-
induced brachial artery vasoconstriction was
small (ranging from 1.2 to 13.9% of luminal
caliber), the effect was notably consistent,
suggested a dose–response relationship, and
was comparable in magnitude to abnormal
coronary vasoconstriction induced by increas-
ing doses of acetylcholine (Anderson et al.
1995; Hambrecht et al. 2000; Takase et al.
1998). In addition, similar magnitude of vaso-
constriction was found in healthy young adults
exposed to concentrated ambient ﬁne particles
and ozone (Brook et al. 2002). Although we
do not postulate that DE-induced vasocon-
striction of this magnitude induces acute car-
diac events, this striking phenomenon and
other sequelae sharing signaling pathways
could result in plaque destabilization, vaso-
spasm, and proarrhythmogenic processes to
explain the consistent epidemiologic observa-
tions of air pollution-induced acute cardiovas-
cular effects. Further, a range of reactions likely
occurs in the large populations exposed to
ambient air pollution, so that a larger magni-
tude of vasoconstriction—including clinically
signiﬁcant vasoconstriction in the most suscep-
tible individuals—could be anticipated. Finally,
small changes seen in epicardial coronaries or
brachial vessels, although not causative of
myocardial infarction, reﬂect processes that are
also occurring in the microvasculature, leading
to arteriolar spasm and capillary derecruitment,
with resulting myocardial ischemia. The recent
ﬁndings by Mills et al. (2007) demonstrating
exercise-induced myocardial ischemia with a
similar exposure (DE at 300 µg/m3) underscore
the relevance of this ﬁnding.
Although individuals with metabolic syn-
drome are at higher risk for cardiovascular
morbidity, and a priori were presumed by us
to be more susceptible to the vascular effects
of DE, we observed greater vasoconstriction
after exposure to DE in the healthy partici-
pants. This may be artifactual because of the
small number of healthy participants with
available preexposure and postexposure BAd
and the higher variability of baseline BAd
compared with participants with metabolic
syndrome (Table 3). However, there may be
biologic reasons for this effect. Healthy indi-
viduals may have more vessel plasticity,
Peretz et al.
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Table 4. Levels of plasma ET-1 and catecholamines (pg/mL).a
FA 200 µg/m3 DE
Biomarker Preexposure Postexposure Preexposure Postexposure
ET-1
Healthy (n = 6) 1.47 ± 0.21 1.35 ± 0.27 0.86 ± 0.06 1.62 ± 0.18
Metabolic syndrome (n = 16) 1.35 ± 0.17 1.41 ± 0.15 1.31 ± 0.18 1.62 ± 0.18
All participants (n = 22) 1.38 ± 0.13 1.39 ± 0.13 1.19 ± 0.14 1.62 ± 0.13
NE
Healthy (n = 5) 128.6 (0.8) 217.4 (1.1) 122.0 (0.9) 227.1 (0.9)
Metabolic syndrome n = 8) 182.7 (0.7) 225.8 (0.7) 175.6 (0.7) 191.8 (0.6)
All participants (n = 13) 161.2 (0.6) 222.7 (0.7) 154.2 (0.6) 203.7 (0.6)
DHPG
Healthy (n = 4) 1090. (0.6) 1294.6 (0.9) 1071.1 (0.7) 1475.6 (0.8)
Metabolic syndrome (n = 8) 919.3 (0.6) 1120.6 (0.7) 830.6 (0.6) 1055.4 (0.6)
All participants (n = 12) 968.7 (0.6) 1171.5 (0.6) 898.2 (0.6) 1170.1 (0.6)
L-DOPA
Healthy (n = 5) 1483.4 (0.7) 1435.5 (0.8) 1474.1 (0.7) 1681.6 (0.7)
Metabolic syndrome (n = 8) 1544.2 (0.6) 1604.7 (0.6) 1363.8 (0.6) 1532.1 (0.6)
All participants (n = 13) 1522.2 (0.6) 1542.1 (0.6) 1402.2 (0.6) 1583.9 (0.6)
DOPAC
Healthy (n = 5) 2386.2 (0.7) 2011.6 (0.7) 2878.4 (0.8) 2313.2 (0.9)
Metabolic syndrome (n = 7) 1469.7 (0.6) 1412.0 (0.6) 1614.2 (0.9) 1945.1 (0.9)
All participants (n = 12) 1770.8 (0.6) 1671.9 (0.6) 2013.4 (0.7) 2079.2 (0.7)
aCatecholamines (all biomarkers except endothelin-1, which is mean ± SE) are presented as geometric mean and geo-
metric standard error of the mean, which is a factor multiplication. 
Figure 2. Changes in hormonal levels from pre-
exposure. Mean changes (95% CIs) of log-
transformed hormonal levels from preexposure to
3 hr from initiating exposure to 200 µg/m3 DE or FA. 
*p = 0.01. #p < 0.05. 
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200 μg/m3 DEexhibiting a greater range of normal vascular
response. Metabolic syndrome is associated
with chronic arterial stiffness and a tonic
constriction of the coronary arteries (Setty
et al. 2003), and thus may be less responsive
to a transient insult derived from a short-term
exposure to DE. Metabolic syndrome is char-
acterized by chronic oxidative stress (Van
Guilder et al. 2006), possibly with conse-
quent up-regulation of antioxidant mecha-
nisms; therefore, these individuals may be
more protected from an oxidative insult
induced by air pollutants. Finally, the effect
of DE on plasma ET-1 was greater in healthy
individuals, which may explain a greater vaso-
constriction in those individuals.
We demonstrated that DE induces a
measurable increase in ET-1 levels in humans,
reﬂecting a perturbation in homeostatic con-
trol of vascular tone, which may have resulted
in the observed brachial artery vasoconstric-
tion. Previous studies have also demonstrated
that the endothelin system may be affected
after inhalation of cigarette smoke (Haak et al.
1994) and air pollutants. Investigations in rats
(Bouthillier et al. 1998; Vincent et al. 2001)
demonstrated an association between urban
air pollution inhalation and increased circulat-
ing levels of ET-1, between diesel soot (but
not carbon black) and plasma ET-3 (Vincent
et al. 2001), and between on-road particles
and ET-2 (Elder et al. 2004). Epidemiologic
studies in children have corroborated the asso-
ciation between air pollution and circulating
ET-1 (Calderon-Garciduenas et al. 2003).
Vincent et al. (2001) showed that increased
levels of plasma ET-1 were associated with
increased systemic blood pressure, suggesting a
role of endothelins in modulating the vascular
effects. In an ex vivo exposure to soluble com-
ponents of DE, coronary arteries from
ApoE–/– mice showed an enhanced response
to ET-1 (Campen et al. 2005).
Increased plasma concentrations of ET-1
can result from either increased synthesis or
decreased clearance. Although we did not
assess ET-1 precursor, which would have pro-
vided a more direct evidence of increased
ET-1 synthesis, there is little reason to specu-
late that decreased clearance occurs as a result
of DE exposure. Increased de novo synthesis
of ET-1 can occur as result of increased
expression of the preproET-1 in the endo-
thelium of any vascular bed, and increased
circulating ET-1 from DE could be attributed
easily to either pulmonary vasculature or sys-
temic arterial endothelium. Our observations
do not provide insight into whether increased
ET-1 was attributable to direct pollutant
effect on systemic vascular endothelium,
increased ET-1 generated in the pulmonary
vasculature, or a downstream effect due to
other circulating mediators elaborated because
of effects in the lung. Thompson et al. (2004)
showed increments in both plasma ET-1 and
preproET-1 mRNA levels in the lungs of rats
exposed to urban particles. To support the
hypothesis that DE may induce pulmonary
synthesis of ET-1 are the facts that endo-
thelium-derived ET-1 is primarily secreted
into the abluminal space (Wagner et al.
1992), and most of it is cleared from the
plasma very fast (Vierhapper et al. 1990). 
It is possible that increased ET-1 synthesis
from DE represents a secondary phenomenon,
such as from stimulation by catecholamines
(Levin 1995). It was suggested that ambient
pollutant particles effect vascular tone through
augmentation of sympathetic activity (Huang
and Ghio 2006), such as by activation of α1
receptors on vascular smooth muscle cells.
Although plasma catecholamine measures are
problematic (Boomsma et al. 1993; Goldstein
et al. 2003), potential involvement of the
autonomic nervous system in the response to
DE cannot be excluded by our data. 
Observation of a higher FMD in a conduit
artery after DE compared with FA does not
support the thesis associating DE particles pri-
marily with inhibition of nitric oxide synthase
in endothelium (Ikeda 1998; Rajagopalan et al.
2005). This does not exclude nitric oxide–
mediated effect of DE on resistance vasculature
as demonstrated by Mills et al. (2005).
Moreover, our study does not exclude the pos-
sibility that DE causes decreased NO bioavail-
ability in association with the observed increase
in ET-1. We cannot exclude non-endothelium-
dependent mechanisms mediating the greater
hyperemic vasodilation of the brachial artery
after DE. Furthermore, it is possible that even
in the setting of DE-induced depletion of NO,
other DE-related factors may have contributed
to a later rise in NO compared with FA. Under
this assumption, a) the higher ET-1 levels after
exposure to DE may have acted on endothelial
ETB receptors, causing direct stimulation of
nitric oxide synthase activity (Cardillo et al.
2000); b) the initiation of vasoconstriction
served as stimulus on the endothelium to
release NO (Harris and Matthews 2004); and
c) possible altered expression of α2B-adreno-
ceptors may have influenced nitric oxide
synthesis (Duling et al. 2006). 
Study limitations. Several limitations in
the study require consideration. First, only a
small number of healthy participants had
available preexposure and postexposure BAd
data. This fact, and the relatively high vari-
ability of BAd in those participants, may have
influenced the greater apparent effect of DE
on BAd in those participants compared with
participants with metabolic syndrome. It
should not be concluded that healthy subjects
are more susceptible.
Furthermore, our observations do not
conﬁrm an increase in ET-1 synthesis, because
the precursor molecule was not measured. In
addition, because of limitations related to
experiments involving human participants,
ET-1 was measured from the systemic circula-
tion, where its concentrations are expected to
be different from those at the level of the tar-
get tissue in the arterial circulation.
Finally, in the absence of an endothelium-
independent vasodilator, we cannot deter-
mine conclusively that the greater maximal
vasodilatation after exposure to DE was not
endothelium dependent.
Conclusions
This study demonstrates a DE effect on control
of conduit arterial tone involving endothelins in
human subjects and suggests a safe experimen-
tal model for further research on cardiovascular
effects of traffic-related air pollution. Taken
together with other research, this experimental
approach, with rigorous control over exposure
situations and potentially confounding factors,
supports the importance of this observation in
elucidating a signiﬁcant mechanistic pathway
underlying the consistent epidemiologic evi-
dence of air pollution-induced cardiovascular
morbidity and mortality. 
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